APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vasodilators

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vasodilators Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchVasodilators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vasodilators Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Vasodilators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vasodilators Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vasodilators Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Vasodilators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vasodilators market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vasodilators market include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vasodilators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vasodilators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vasodilators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vasodilators market size, projected growth trends, production technologies, key applications, and end-use industries.

Vasodilators Segment by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

Vasodilators Segment by Type

Venous Dilators

Mixed Dilators

Arterial Dilators

Vasodilators Segment by Application

Heart Failure

Angina

Hypertension

Vasodilators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vasodilators status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vasodilators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vasodilators significant trends, drivers, influence factors in global and regions.

6. To analyze Vasodilators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasodilators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vasodilators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasodilators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vasodilators market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vasodilators industry.

Chapter 3: Detailed analysis of Vasodilators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vasodilators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vasodilators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vasodilators Industry Trends Table 2. Vasodilators Industry Drivers Table 3. Vasodilators Industry Opportunities and Challenges Table 4. Vasodilators Industry Restraints Table 5. Global Vasodilators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vasodilators Revenue Share by Company (2021-2026) Table 7. Global Vasodilators Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Vasodilators Sales Volume Share by Company (2021-2026) Table 9. Global Vasodilators Average Price (US$/ton) of Company (2021-2026) Table 10. Global Vasodilators Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vasodilators Key Company Manufacturing Base & Headquarters Table 12. Global Vasodilators Company, Product Type & Application Table 13. Global Vasodilators Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vasodilators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Venous Dilators Table 18. Significant Companies of Mixed Dilators Table 19. Significant Companies of Arterial Dilators Table 20. Global Vasodilators Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Vasodilators Sales Volume by Type (2021-2026) & (k tons) Table 22. Global Vasodilators Sales Volume by Type (2027-2032) & (k tons) Table 23. Global Vasodilators Sales Volume Share by Type (2021-2026) Table 24. Global Vasodilators Sales Volume Share by Type (2027-2032) Table 25. Global Vasodilators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vasodilators Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Vasodilators Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Vasodilators Sales Value Share by Type (2021-2026) Table 29. Global Vasodilators Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Heart Failure Table 31. Significant Companies of Angina Table 32. Significant Companies of Hypertension Table 33. Global Vasodilators Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 34. Global Vasodilators Sales Volume by Application (2021-2026) & (k tons) Table 35. Global Vasodilators Sales Volume by Application (2027-2032) & (k tons) Table 36. Global Vasodilators Sales Volume Share by Application (2021-2026) Table 37. Global Vasodilators Sales Volume Share by Application (2027-2032) Table 38. Global Vasodilators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Vasodilators Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Vasodilators Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Vasodilators Sales Value Share by Application (2021-2026) Table 42. Global Vasodilators Sales Value Share by Application (2027-2032) Table 43. Global Vasodilators Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 44. Global Vasodilators Sales by Region (2021-2026) & (k tons) Table 45. Global Vasodilators Sales Market Share by Region (2021-2026) Table 46. Global Vasodilators Sales by Region (2027-2032) & (k tons) Table 47. Global Vasodilators Sales Market Share by Region (2027-2032) Table 48. Global Vasodilators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Vasodilators Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Vasodilators Sales Value Share by Region (2021-2026) Table 51. Global Vasodilators Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Vasodilators Sales Value Share by Region (2027-2032) Table 53. Global Vasodilators Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global Vasodilators Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global Vasodilators Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. Global Vasodilators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Vasodilators Sales by Country (2021-2026) & (k tons) Table 58. Global Vasodilators Sales Market Share by Country (2021-2026) Table 59. Global Vasodilators Sales by Country (2027-2032) & (k tons) Table 60. Global Vasodilators Sales Market Share by Country (2027-2032) Table 61. Global Vasodilators Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Vasodilators Sales Value Market Share by Country (2021-2026) Table 63. Global Vasodilators Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Vasodilators Sales Value Market Share by Country (2027-2032) Table 65. Teva Pharmaceutical Company Information Table 66. Teva Pharmaceutical Business Overview Table 67. Teva Pharmaceutical Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Vasodilators Product Portfolio Table 69. Teva Pharmaceutical Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Sanofi Vasodilators Product Portfolio Table 74. Sanofi Recent Development Table 75. Jhonson and Johnson Company Information Table 76. Jhonson and Johnson Business Overview Table 77. Jhonson and Johnson Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Jhonson and Johnson Vasodilators Product Portfolio Table 79. Jhonson and Johnson Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Novartis Vasodilators Product Portfolio Table 84. Novartis Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Merck Vasodilators Product Portfolio Table 89. Merck Recent Development Table 90. Eli Lilly Company Information Table 91. Eli Lilly Business Overview Table 92. Eli Lilly Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Eli Lilly Vasodilators Product Portfolio Table 94. Eli Lilly Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. Pfizer Vasodilators Product Portfolio Table 99. Pfizer Recent Development Table 100. GSK Company Information Table 101. GSK Business Overview Table 102. GSK Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. GSK Vasodilators Product Portfolio Table 104. GSK Recent Development Table 105. Bayer Company Information Table 106. Bayer Business Overview Table 107. Bayer Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. Bayer Vasodilators Product Portfolio Table 109. Bayer Recent Development Table 110. Bristol-Myers Squibb Company Information Table 111. Bristol-Myers Squibb Business Overview Table 112. Bristol-Myers Squibb Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. Bristol-Myers Squibb Vasodilators Product Portfolio Table 114. Bristol-Myers Squibb Recent Development Table 115. Astra Zeneca Company Information Table 116. Astra Zeneca Business Overview Table 117. Astra Zeneca Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. Astra Zeneca Vasodilators Product Portfolio Table 119. Astra Zeneca Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Vasodilators Distributors List Table 123. Vasodilators Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Vasodilators Product Image Figure 2. Global Vasodilators Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vasodilators Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vasodilators Sales (2021-2032) & (k tons) Figure 5. Global Vasodilators Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Vasodilators Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Venous Dilators Image Figure 10. Mixed Dilators Image Figure 11. Arterial Dilators Image Figure 12. Global Vasodilators Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Vasodilators Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Vasodilators Sales Volume Share by Type (2021-2032) Figure 15. Global Vasodilators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Vasodilators Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Vasodilators Sales Value Share by Type (2021-2032) Figure 18. Heart Failure Image Figure 19. Angina Image Figure 20. Hypertension Image Figure 21. Global Vasodilators Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 22. Global Vasodilators Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Vasodilators Sales Volume Share by Application (2021-2032) Figure 24. Global Vasodilators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Vasodilators Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Vasodilators Sales Value Share by Application (2021-2032) Figure 27. Global Vasodilators Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 28. Global Vasodilators Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Vasodilators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Vasodilators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Vasodilators Sales Value (2021-2032) & (US$ Million) Figure 32. North America Vasodilators Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Vasodilators Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Vasodilators Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Vasodilators Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Vasodilators Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Vasodilators Sales Value (2021-2032) & (US$ Million) Figure 38. South America Vasodilators Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Vasodilators Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Vasodilators Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Vasodilators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Vasodilators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Vasodilators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Vasodilators Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Vasodilators Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Venous Dilators
  • Mixed Dilators
  • Arterial Dilators
Applications
  • Heart Failure
  • Angina
  • Hypertension
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vasodilators Sales Value (2021-2032)
  4. 1.2.2 Global Vasodilators Sales Volume (2021-2032)
  5. 1.2.3 Global Vasodilators Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vasodilators Market Dynamics
  1. 2.1 Vasodilators Industry Trends
  2. 2.2 Vasodilators Industry Drivers
  3. 2.3 Vasodilators Industry Opportunities and Challenges
  4. 2.4 Vasodilators Industry Restraints
3 Vasodilators Market by Company
  1. 3.1 Global Vasodilators Company Revenue Ranking in 2025
  2. 3.2 Global Vasodilators Revenue by Company (2021-2026)
  3. 3.3 Global Vasodilators Sales Volume by Company (2021-2026)
  4. 3.4 Global Vasodilators Average Price by Company (2021-2026)
  5. 3.5 Global Vasodilators Company Ranking (2024-2026)
  6. 3.6 Global Vasodilators Company Manufacturing Base and Headquarters
  7. 3.7 Global Vasodilators Company Product Type and Application
  8. 3.8 Global Vasodilators Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vasodilators Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vasodilators Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vasodilators Market by Type
  1. 4.1 Vasodilators Type Introduction
  2. 4.1.1 Venous Dilators
  3. 4.1.2 Mixed Dilators
  4. 4.1.3 Arterial Dilators
  5. 4.2 Global Vasodilators Sales Volume by Type
  6. 4.2.1 Global Vasodilators Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vasodilators Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Vasodilators Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Vasodilators Sales Value by Type
  10. 4.3.1 Global Vasodilators Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vasodilators Sales Value by Type (2021-2032)
  12. 4.3.3 Global Vasodilators Sales Value Share by Type (2021-2032)
5 Vasodilators Market by Application
  1. 5.1 Vasodilators Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Angina
  4. 5.1.3 Hypertension
  5. 5.2 Global Vasodilators Sales Volume by Application
  6. 5.2.1 Global Vasodilators Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vasodilators Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Vasodilators Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Vasodilators Sales Value by Application
  10. 5.3.1 Global Vasodilators Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vasodilators Sales Value by Application (2021-2032)
  12. 5.3.3 Global Vasodilators Sales Value Share by Application (2021-2032)
6 Vasodilators Regional Sales and Value Analysis
  1. 6.1 Global Vasodilators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vasodilators Sales by Region (2021-2032)
  3. 6.2.1 Global Vasodilators Sales by Region: 2021-2026
  4. 6.2.2 Global Vasodilators Sales by Region (2027-2032)
  5. 6.3 Global Vasodilators Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vasodilators Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vasodilators Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vasodilators Sales Value by Region (2027-2032)
  9. 6.5 Global Vasodilators Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vasodilators Sales Value (2021-2032)
  12. 6.6.2 North America Vasodilators Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vasodilators Sales Value (2021-2032)
  15. 6.7.2 Europe Vasodilators Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vasodilators Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vasodilators Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vasodilators Sales Value (2021-2032)
  21. 6.9.2 South America Vasodilators Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vasodilators Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vasodilators Sales Value Share by Country, 2025 VS 2032
7 Vasodilators Country-level Sales and Value Analysis
  1. 7.1 Global Vasodilators Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vasodilators Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vasodilators Sales by Country (2021-2032)
  4. 7.3.1 Global Vasodilators Sales by Country (2021-2026)
  5. 7.3.2 Global Vasodilators Sales by Country (2027-2032)
  6. 7.4 Global Vasodilators Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vasodilators Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vasodilators Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vasodilators Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vasodilators Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vasodilators Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vasodilators Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vasodilators Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vasodilators Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vasodilators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vasodilators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vasodilators Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vasodilators Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vasodilators Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vasodilators Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vasodilators Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vasodilators Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vasodilators Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vasodilators Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vasodilators Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vasodilators Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vasodilators Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vasodilators Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vasodilators Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vasodilators Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vasodilators Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vasodilators Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vasodilators Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vasodilators Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vasodilators Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vasodilators Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vasodilators Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vasodilators Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vasodilators Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vasodilators Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vasodilators Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vasodilators Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vasodilators Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vasodilators Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vasodilators Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vasodilators Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vasodilators Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vasodilators Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vasodilators Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vasodilators Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vasodilators Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vasodilators Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vasodilators Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vasodilators Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vasodilators Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vasodilators Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vasodilators Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vasodilators Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vasodilators Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vasodilators Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vasodilators Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vasodilators Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vasodilators Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vasodilators Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vasodilators Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vasodilators Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vasodilators Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vasodilators Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vasodilators Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vasodilators Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vasodilators Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vasodilators Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vasodilators Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vasodilators Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vasodilators Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vasodilators Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vasodilators Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vasodilators Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vasodilators Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vasodilators Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vasodilators Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vasodilators Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vasodilators Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vasodilators Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vasodilators Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vasodilators Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vasodilators Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vasodilators Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vasodilators Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vasodilators Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vasodilators Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vasodilators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Vasodilators Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Vasodilators Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Vasodilators Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Vasodilators Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Jhonson and Johnson
  14. 8.3.1 Jhonson and Johnson Company Information
  15. 8.3.2 Jhonson and Johnson Business Overview
  16. 8.3.3 Jhonson and Johnson Vasodilators Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jhonson and Johnson Vasodilators Product Portfolio
  18. 8.3.5 Jhonson and Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Vasodilators Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Vasodilators Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Vasodilators Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Vasodilators Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Vasodilators Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Vasodilators Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Vasodilators Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Vasodilators Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Vasodilators Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GSK Vasodilators Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Vasodilators Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Vasodilators Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Bristol-Myers Squibb
  56. 8.10.1 Bristol-Myers Squibb Company Information
  57. 8.10.2 Bristol-Myers Squibb Business Overview
  58. 8.10.3 Bristol-Myers Squibb Vasodilators Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bristol-Myers Squibb Vasodilators Product Portfolio
  60. 8.10.5 Bristol-Myers Squibb Recent Developments
  61. 8.11 Astra Zeneca
  62. 8.11.1 Astra Zeneca Company Information
  63. 8.11.2 Astra Zeneca Business Overview
  64. 8.11.3 Astra Zeneca Vasodilators Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Astra Zeneca Vasodilators Product Portfolio
  66. 8.11.5 Astra Zeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vasodilators Value Chain Analysis
  2. 9.1.1 Vasodilators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vasodilators Sales Mode & Process
  6. 9.2 Vasodilators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vasodilators Distributors
  9. 9.2.3 Vasodilators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst